FDA recall D-0341-2019

CBI Laboratories, Inc. · Class III · drug

Product

Advanced Protection Sunscreen spf 30 (Octinoxate 7.5%, Octisalate 5%, Oxybenzone 6%), 4.5 Oz/127.5 g tube.

Reason for recall

Subpotent Drug:Out of specification for percentage of active pharmaceutical ingredients.

Distribution

United States, Maldives, Canada, United Arab Emirates, and New Zealand

Key facts

Status
Terminated
Initiation date
2018-12-10
Report date
2018-12-26
Termination date
2020-01-14
Voluntary/Mandated
Voluntary: Firm initiated
Location
Fort Worth, TX, United States

Primary source

https://www.accessdata.fda.gov/scripts/ires/index.cfm?Product=D-0341-2019